Abstract
Natural products have long been valuable sources of inspiration for drug discovery. Unfortunately, the inherent limitations of direct semisynthetic derivatizations have become clear, and the need to overcome these limitations is now particularly urgent because the most valuable natural products tend to be isolated in minute amounts; de novo synthesis with ideal modularity and diversity is therefore a critical goal in drug discovery research. Herein we report a powerful, general platform for cyclolignan synthesis that involves challenging rhodium-catalysed enantioselective hydrogenation of tetrasubstituted 1,2-dihydronaphthalene esters (>40 examples; up to 99% yield, >99% e.e.). This unique platform allows ready access to various types of cyclolignans, as exemplified by the expedient and mostly protecting-group-free synthesis of over thirty cyclolignans, including many that have not previously been synthesized, such as 6-methoxy podophyllotoxin, cleistantoxin, picrobursenin, austrobailignan-4, (+)-lirionol, (+)-gaultherin C, ovafolinin D, fimbricalyxoid A, and aglacins D, F–H (with three revised structures). We expect this work to inspire modular, de novo syntheses of other important classes of natural products and thus to rejuvenate the role of natural products in drug discovery and development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The X-ray crystallographic coordinates for structures reported in this study have been deposited at the Cambridge Crystallographic Data Centre (CCDC), under deposition nos. CCDC 2261541 (2p), 2232313 (9), 2236506 (16), 2236638 [(±)-47], 2236477 (71), 2289443 (81), 2236507 (S9) and 2272028 (S24). These data can be obtained free of charge from the CCDC via www.ccdc.cam.ac.uk/data_request/cif. All other relevant data generated and analysed during this study, including experimental, spectroscopic and crystallographic data, are included in this Article and its Supplementary Information.
Change history
27 June 2024
A Correction to this paper has been published: https://doi.org/10.1038/s44160-024-00613-6
References
Vassão, D. G., Kim, K.-W., Davin, L. B. & Lewis, N. G. Lignans (neolignans) and allyl/propenyl phenols: biogenesis, structural biology, and biological/human health considerations. Comprehensive Natural Products II 1, 815–928 (2010).
Bruno, B., Giulliano Delle, M., Domenico, M., Alberto, V. & Giovanni, Z. Aryltetralin lignans: chemistry, pharmacology and biotransformations. Curr. Med. Chem. 8, 1363–1381 (2001).
Shah, Z. et al. Podophyllotoxin: history, recent advances and future prospects. Biomolecules 11, 603–630 (2021).
Yu, X., Che, Z. & Xu, H. Recent advances in the chemistry and biology of podophyllotoxins. Chem. Eur. J. 23, 4467–4526 (2017).
Reynolds, R. G., Nguyen, H. Q. A., Reddel, J. C. T. & Thomson, R. J. Recent strategies and tactics for the enantioselective total syntheses of cyclolignan natural products. Nat. Prod. Rep. 39, 670–702 (2022).
Fang, X. & Hu, X. Advances in the synthesis of lignan natural products. Molecules 23, 3385 (2018).
Zhao, W. et al. Challenges and Potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy. Nat. Prod. Rep. 38, 470–488 (2021).
Andrews, R. C., Teague, S. J. & Meyers, A. I. Asymmetric total synthesis of (–)-podophyllotoxin. J. Am. Chem. Soc. 110, 7854–7858 (1988).
Hajra, S., Garai, S. & Hazra, S. Catalytic enantioselective synthesis of (–)-podophyllotoxin. Org. Lett. 19, 6530–6533 (2017).
Charest, M. G., Lerner, C. D., Brubaker, J. D., Siegel, D. R. & Myers, A. G. A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. Science 308, 395–398 (2005).
Seiple, I. B. et al. A platform for the discovery of new macrolide antibiotics. Nature 533, 338–345 (2016).
Li, Q. et al. Synthetic group A streptogramin antibiotics that overcome Vat resistance. Nature 586, 145–150 (2020).
Mitcheltree, M. J. et al. A synthetic antibiotic class overcoming bacterial multidrug resistance. Nature 599, 507–512 (2021).
Smith, P. A. et al. Optimized arylomycins are a new class of Gram-negative antibiotics. Nature 651, 189–194 (2018).
Murphy, S. K., Zeng, M. & Herzon, S. B. A modular and enantioselective synthesis of the pleuromutilin antibiotics. Science 356, 956–959 (2017).
Wang, X. et al. A radical cascade enabling collective syntheses of natural products. Chem 2, 803–816 (2017).
Zhang, X. et al. Divergent synthesis of complex diterpenes through a hybrid oxidative approach. Science 369, 799–806 (2020).
Harwood, S. J. et al. Modular terpene synthesis enabled by mild electrochemical couplings. Science 375, 745–752 (2022).
Scharf, M. J. & List, B. A catalytic asymmetric Pictet–Spengler platform as a biomimetic diversification strategy toward naturally occurring alkaloids. J. Am. Chem. Soc. 144, 15451–15456 (2022).
Goethe, O., DiBello, M. & Herzon, S. B. Total synthesis of structurally diverse pleuromutilin antibiotics. Nat. Chem. 14, 1270–1277 (2022).
Reddel, J. C. T., Lutz, K. E., Diagne, A. B. & Thomson, R. J. Stereocontrolled syntheses of tetralone and naphthyl-type lignans by a one-pot oxidative [3,3] rearrangement/Friedel–Crafts arylation. Angew. Chem. Int. Ed. 53, 1395–1398 (2014).
Ting, C. P. & Maimone, T. J. C–H Bond arylation in the synthesis of aryltetralin lignans: a short total synthesis of podophyllotoxin. Angew. Chem. Int. Ed. 53, 3115–3119 (2014).
Xiao, J., Cong, X.-W., Yang, G.-Z., Wang, Y.-W. & Peng, Y. Divergent asymmetric syntheses of podophyllotoxin and related family members via stereoselective reductive Ni-catalysis. Org. Lett. 20, 1651–1654 (2018).
Li, J., Zhang, X. & Renata, H. Asymmetric chemoenzymatic synthesis of (–)-podophyllotoxin and related aryltetralin lignans. Angew. Chem. Int. Ed. 58, 11657–11660 (2019).
Lazzarotto, M. et al. Chemoenzymatic total synthesis of deoxy-, epi-, and podophyllotoxin and a biocatalytic kinetic resolution of dibenzylbutyrolactones. Angew. Chem. Int. Ed. 58, 8226–8230 (2019).
Xiang, J.-C., Wang, Q. & Zhu, J. Radical-cation cascade to aryltetralin cyclic ether lignans under visible-light photoredox catalysis. Angew. Chem. Int. Ed. 59, 21195–21202 (2020).
Xu, M., Hou, M., He, H. & Gao, S. Asymmetric total synthesis of aglacins A, B, and E. Angew. Chem. Int. Ed. 60, 16655–16660 (2021).
Cao, M.-Y. et al. Optically active flavaglines-inspired molecules by a palladium-catalyzed decarboxylative dearomative asymmetric allylic alkylation. J. Am. Chem. Soc. 142, 12039–12045 (2020).
Sun, A. W., Lackner, S. & Stoltz, B. M. Modularity: adding new dimensions to total synthesis. Trends Chem. 1, 630–643 (2019).
Corey, E. J. & Cheng, X.-M. The Logic of Chemical Synthesis (Wiley, 1989).
Hendrickson, J. B. Systematic synthesis design. IV. Numerical codification of construction reactions. J. Am. Chem. Soc. 97, 5784–5800 (1975).
Wender, P. A. Toward the ideal synthesis and transformative therapies: the roles of step economy and function oriented synthesis. Tetrahedron 69, 7529–7550 (2013).
Peters, D. S. et al. Ideality in context: motivations for total synthesis. Acc. Chem. Res. 54, 605–617 (2021).
Cao, M.-Y., Ma, B.-J., Gu, Q.-X., Fu, B. & Lu, H.-H. Concise enantioselective total synthesis of daphenylline enabled by an intramolecular oxidative dearomatization. J. Am. Chem. Soc. 144, 5750–5755 (2022).
Kraft, S., Ryan, K. & Kargbo, R. B. Recent advances in asymmetric hydrogenation of tetrasubstituted olefins. J. Am. Chem. Soc. 139, 11630–11641 (2017).
Margarita, C. & Andersson, P. G. Evolution and prospects of the asymmetric hydrogenation of unfunctionalized olefins. J. Am. Chem. Soc. 139, 1346–1356 (2017).
Bigler, R. et al. Asymmetric hydrogenation of unfunctionalized tetrasubstituted acyclic olefins. Angew. Chem. Int. Ed. 59, 2844–2849 (2019).
Biosca, M. et al. Extending the substrate scope in the hydrogenation of unfunctionalized tetrasubstituted olefins with Ir-P stereogenic aminophosphine–oxazoline catalysts. Org. Lett. 21, 807–811 (2019).
Zhang, J.-H. et al. Highly enantio- and diastereoselective hydrogenation of cyclic tetrasubstituted β-enamido phosphorus derivatives. Angew. Chem. Int. Ed. 62, e202305315 (2023).
Faiges, J. et al. Unlocking the asymmetric hydrogenation of tetrasubstituted acyclic enones. Angew. Chem. Int. Ed. 62, e202305315 (2023).
Zhao, Q.-K. et al. Asymmetric hydrogenation of β-aryl alkylidene malonate esters: installing an ester group significantly increases the efficiency. Org. Lett. 23, 1675–1680 (2021).
Molinaro, C. et al. A practical synthesis of renin inhibitor MK-1597 (ACT-178882) via catalytic enantioselective hydrogenation and epimerization of piperidine intermediate. J. Org. Chem. 76, 1062–1071 (2011).
Campeau, L.-C. et al. Convergent kilo-scale synthesis of a potent renin inhibitor for the treatment of hypertension. Org. Process Res. Dev. 15, 1138–1148 (2011).
Christensen, M. et al. Enantioselective synthesis of α-methyl-β-cyclopropyldihydrocinnamates. J. Org. Chem. 81, 824–830 (2016).
Kerdphon, S. et al. Diastereo- and enantioselective synthesis of structurally diverse succinate, butyrolactone, and trifluoromethyl derivatives by iridium-catalyzed hydrogenation of tetrasubstituted olefins. ACS Catal. 9, 6169–6176 (2019).
Liu, Y.-T. et al. Asymmetric hydrogenation of tetrasubstituted cyclic enones to chiral cycloalkanols with three contiguous stereocenters. Org. Lett. 19, 3231–3234 (2017).
Zhao, Q.-K. et al. Catalytic asymmetric hydrogenation of 3‑ethoxycarbonyl quinolin-2-ones and coumarins. Org. Lett. 23, 3593–3598 (2021).
Zhu, Z.-H., Ding, Y.-X., Wu, B. & Zhou, Y.-G. Biomimetic asymmetric reduction of tetrasubstituted olefin 2,3-disubstituted inden-1-ones with chiral and regenerable NAD(P)H model CYNAM. Org. Lett. 23, 7166–7170 (2021).
Yin, C., Pan, Y., Zhang, X. & Yin, Q. Catalytic asymmetric hydrogenation of tetrasubstituted unsaturated lactams: an efficient approach to enantioenriched 3,4-disubstituted piperidines. Org. Lett. 24, 675–680 (2022).
Li, C. et al. Stereoelectronic effects in ligand design: enantioselective rhodium catalyzed hydrogenation of aliphatic cyclic tetrasubstituted enamides and concise synthesis of (R)-tofacitinib. Angew. Chem. Int. Ed. 58, 13573–13583 (2019).
Song, S., Zhu, S.-F., Li, Y. & Zhou, Q.-L. Iridium-catalyzed enantioselective hydrogenation of α,β-unsaturated carboxylic acids with tetrasubstituted olefins. Org. Lett. 15, 3722–3725 (2013).
Du, X. et al. Enantioselective hydrogenation of tetrasubstituted α,β-unsaturated carboxylic acids enabled by cobalt(II) catalysis: scope and mechanistic insights. Angew. Chem. Int. Ed. 60, 11384–11390 (2021).
Chen, G.-Q. et al. Highly enantioselective hydrogenation of tetra- and tri-substituted α,β-unsaturated carboxylic acids with oxa-spiro diphosphine ligands. CCS Chem. 2, 468–477 (2020).
Zhang, M. et al. Asymmetric hydrogenation of all-carbon tetrasubstituted α-acylpyrazole-β-alkyl cycloalkenes. Org. Chem. Front. 10, 5070–5075 (2023).
Troutman, M. V., Appella, D. H. & Buchwald, S. L. Asymmetric hydrogenation of unfunctionalized tetrasubstituted olefins with a cationic zirconocene catalyst. J. Am. Chem. Soc. 121, 4916–4917 (1999).
Schrems, M. G., Neumann, E. & Pfaltz, A. Iridium-catalyzed asymmetric hydrogenation of unfunctionalized tetrasubstituted olefins. Angew. Chem. Int. Ed. 46, 8274–8276 (2007).
Zhang, Z., Zhu, G., Jiang, Q., Xiao, D. & Zhang, X. Highly enantioselective hydrogenation of cyclic enamides catalyzed by a Rh-PennPhos catalyst. J. Org. Chem. 64, 1774–1775 (1999).
Dobbs, D. A. et al. Industrial synthesis of (+)-cis-methyl dihydrojasmonate by enantioselective catalytic hydrogenation; identification of the precatalyst [Ru((−)-Me-DuPHOS)(H)(η6-1,3,5-cyclooctatriene)](BF4). Angew. Chem. Int. Ed. 39, 1992–1995 (2000).
Zhang, Z. et al. Total synthesis and stereochemical assignment of delavatine A: Rh-catalyzed asymmetric hydrogenation of indene-type tetrasubstituted olefins and kinetic resolution through Pd-catalyzed triflamide-directed C–H olefination. J. Am. Chem. Soc. 139, 5558–5567 (2017).
MacNeil, P. A., Roberts, N. K. & Bosnich, B. Asymmetric synthesis. Asymmetric catalytic hydrogenation using chiral chelating six-membered ring diphosphines. J. Am. Chem. Soc. 103, 2273–2280 (1981).
Bakos, J., Toth, I. & Marko, L. Use of heterogeneous asymmetric hydrogenation for the preparation of a chiral phosphinite and its application as a ligand in homogeneous asymmetric hydrogenation. J. Org. Chem. 46, 5427–5428 (1981).
Yamada, M., Kato, T., Ikemoto, T. & Yamano, M. Rhodium-catalyzed highly enantioselective hydrogenation of a tetrasubstituted enamine. Org. Process Res. Dev. 25, 1074–1079 (2021).
Lubov, D. P., Talsi, E. P. & Bryliakov, K. P. Methods for selective benzylic C–H oxofunctionalization of organic compounds. Russ. Chem. Rev. 89, 587–628 (2020).
Forsey, S. P., Rajapaksa, D., Taylor, N. J. & Rodrigo, R. Comprehensive synthetic route to eight diastereomeric podophyllum lignans. J. Org. Chem. 54, 4280–4290 (1989).
Kuo, Y.-H. & Yu, M.-T. A new lignan, formosalactone, from the bark of Juniperus formosana Hay. var. concolor Hay. Heterocycles 36, 529–535 (1993).
Ito, J., Sakuma, D. & Nishii, Y. First total synthesis of (+)-podophyllic aldehydes. Chem. Lett. 44, 297–299 (2015).
Weeratunga, G., Rajapaksa, D. & Rodrigo, R. The synthesis and relative configuration of (±)-lirionol. J. Org. Chem. 50, 5902–5905 (1985).
Wang, B.-G., Ebel, R., Wang, C.-Y., Wray, V. & Peter, P. New methoxylated aryltetrahydronaphthalene lignans and a norlignan from Aglaia cordata. Tetrahedron Lett. 43, 5783–5787 (2002).
Wang, B.-G. et al. Aglacins A-D: first representatives of a new class of aryltetralin cyclic ether lignans from Aglaia cordata. J. Nat. Prod. 64, 1521–1526 (2001).
Paolillo, J. M., Duke, A. D., Gogarnoiu, E. S., Wise, D. E. & Parasram, M. Anaerobic hydroxylation of C(sp3)–H bonds enabled by the synergistic nature of photoexcited nitroarenes. J. Am. Chem. Soc. 145, 2794–2799 (2023).
Li, L.-P. et al. Total synthesis of the alleged structure of (+)-fimbricalyxoid A. Org. Lett. 24, 3477–3481 (2022).
Acknowledgements
We are grateful to the National Natural Science Foundation of China (grant no. 22271236) and the Natural Science Foundation of Zhejiang Province (grant no. LXZ22B020001) for support of this research. We sincerely thank T. J. Schmidt (University of Münster) and Y. S. Yun (Tokyo University of Pharmacy and Life Sciences) for kindly providing us with their original NMR spectra for 6-methoxypodophyllotoxin-7-O-n-hexanoate and ovafonin D, respectively. We acknowledge R. Shenvi (Scripps Research) for helpful discussions; J. Liu from the Chemistry Instrumentation Center at Zhejiang University for X-ray crystallographic analysis; and the Instrumentation and Service Centre for Molecular Sciences, and the Instrumentation and Service Centre for Physical Science at Westlake University, for help with other data analyses.
Author information
Authors and Affiliations
Contributions
H.-H.L. conceived the project, guided the studies, and wrote the manuscript. Z.P. developed the asymmetric hydrogenation and completed the synthesis of podophyllotoxins and related cyclolignans. W.-X.X. completed the syntheses of lirionol, aglacins, gaultherin C, ovafolinin D and fimbricalyxoid A. Q.-X.G., Y.Z. and L.-H.Z. helped with the preparation of some intermediates. F.L. provided further X-ray crystallographic analysis and justifications. All of the authors contributed to the analysis and interpretation of the results.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Synthesis thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editor: Peter Seavill, in collaboration with the Nature Synthesis team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Figs. 1–16, Tables 1–25 and experimental details.
Supplementary Data 1
X-ray crystallographic data for compound 2p (CCDC 2261541).
Supplementary Data 2
X-ray crystallographic data for compound 9 (CCDC 2232313).
Supplementary Data 3
X-ray crystallographic data for compound 16 (CCDC 2236506).
Supplementary Data 4
X-ray crystallographic data for compound 47 (CCDC 2236638).
Supplementary Data 5
X-ray crystallographic data for compound 71 (CCDC 2236477).
Supplementary Data 6
X-ray crystallographic data for compound 81 (CCDC 2289443).
Supplementary Data 7
X-ray crystallographic data for compound S9 (CCDC 2236507).
Supplementary Data 8
X-ray crystallographic data for compound S24 (CCDC 2272028).
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xu, WX., Peng, Z., Gu, QX. et al. Cyclolignan synthesis streamlined by enantioselective hydrogenation of tetrasubstituted olefins. Nat. Synth 3, 986–997 (2024). https://doi.org/10.1038/s44160-024-00564-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44160-024-00564-y
This article is cited by
-
Hydrogenation streamlines cyclolignan synthesis
Nature Synthesis (2024)